{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:58:53Z","timestamp":1790204333902,"version":"4.1.0"},"posted":{"date-parts":[[2024,5,21]]},"group-title":"In Review","reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,16]]},"abstract":"<title>Abstract<\/title>\n        <p>\u0394<sup>9<\/sup>-tetrahydrocannabinol (THC) is the principal psychoactive compound derived from the cannabis plant Cannabis sativa and approved for emetic conditions, appetite stimulation and sleep apnea relief. THC\u2019s psychoactive actions are mediated primarily by the cannabinoid receptor CB<sub>1<\/sub>. Here, we determine the cryo-EM structure of HU210, a THC analog and widely used tool compound, bound to CB<sub>1<\/sub> and its primary transducer, G<sub>i1<\/sub>. We leverage this structure for docking and 1,000 ns molecular dynamics simulations of THC and 10 structural analogs delineating their spatiotemporal interactions at the molecular level. Furthermore, we pharmacologically profile their recruitment of G<sub>i<\/sub> and \u03b2-arrestins and reversibility of binding from an active complex. By combining detailed CB<sub>1<\/sub> structural information with molecular models and signaling data we uncover the differential spatiotemporal interactions these ligands make to receptors governing potency, efficacy, bias and kinetics. This may help explain the actions of abused substances, advance fundamental receptor activation studies and design better medicines.<\/p>","DOI":"10.21203\/rs.3.rs-4277209\/v1","type":"posted-content","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T09:16:26Z","timestamp":1716282986000},"source":"Crossref","is-referenced-by-count":1,"title":["Structural basis of \u03949-THC analog activity at the Cannabinoid 1 receptor"],"prefix":"10.21203","author":[{"given":"Thor","family":"Thorsen","sequence":"first","affiliation":[{"name":"University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashraj","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-888X","authenticated-orcid":false,"given":"David","family":"Sykes","sequence":"additional","affiliation":[{"name":"University of Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-3521","authenticated-orcid":false,"given":"Andreas","family":"B\u00f8ggild","sequence":"additional","affiliation":[{"name":"Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Drace","sequence":"additional","affiliation":[{"name":"Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarin","family":"Hompluem","sequence":"additional","affiliation":[{"name":"University of Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Iliopoulos-Tsoutsouvas","sequence":"additional","affiliation":[{"name":"Northeastern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-5292","authenticated-orcid":false,"given":"Spyros","family":"Nikas","sequence":"additional","affiliation":[{"name":"Northeastern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-5033","authenticated-orcid":false,"given":"Henrik","family":"Daver","sequence":"additional","affiliation":[{"name":"University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Makriyannis","sequence":"additional","affiliation":[{"name":"Northeastern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul","family":"Nissen","sequence":"additional","affiliation":[{"name":"Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-2287","authenticated-orcid":false,"given":"Michael","family":"Gajhede","sequence":"additional","affiliation":[{"name":"University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-5409","authenticated-orcid":false,"given":"Dmitry","family":"Veprintsev","sequence":"additional","affiliation":[{"name":"University of Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Boesen","sequence":"additional","affiliation":[{"name":"Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Kastrup","sequence":"additional","affiliation":[{"name":"University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-7561","authenticated-orcid":false,"given":"David","family":"Gloriam","sequence":"additional","affiliation":[{"name":"University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone M","year":"2015","unstructured":"Maccarrone M et al (2015) Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci 36:277\u2013296. 10.1016\/j.tips.2015.02.008","journal-title":"Trends Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years","volume":"75","author":"Maccarrone M","year":"2023","unstructured":"Maccarrone M et al (2023) Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev 75:885\u2013958. 10.1124\/pharmrev.122.000600","journal-title":"Pharmacol Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"101473","DOI":"10.1016\/j.smrv.2021.101473","article-title":"New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review","volume":"57","author":"Schutz SG","year":"2021","unstructured":"Schutz SG, Dunn A, Braley TJ, Pitt B, Shelgikar AV (2021) New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review. Sleep Med Rev 57:101473. 10.1016\/j.smrv.2021.101473","journal-title":"Sleep Med Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0022","DOI":"10.5041\/RMMJ.10129","article-title":"The endocannabinoid system, cannabinoids, and pain","volume":"4","author":"Fine PG","year":"2013","unstructured":"Fine PG, Rosenfeld MJ (2013) The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J 4:e0022. 10.5041\/RMMJ.10129","journal-title":"Rambam Maimonides Med J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","article-title":"The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews","volume":"18","author":"Nielsen S","year":"2018","unstructured":"Nielsen S et al (2018) The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. Curr Neurol Neurosci Rep 18:8. 10.1007\/s11910-018-0814-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino L","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 16:9\u201329. 10.1038\/s41582-019-0284-z","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee RG","year":"2006","unstructured":"Pertwee RG (2006) The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes (Lond) 30(1):13\u201318. 10.1038\/sj.ijo.0803272","journal-title":"Int J Obes (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1098\/rstb.2000.0787","article-title":"The neurobiology and evolution of cannabinoid signalling","volume":"356","author":"Elphick MR","year":"2001","unstructured":"Elphick MR, Egertova M (2001) The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 356:381\u2013408. 10.1098\/rstb.2000.0787","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass M","year":"1997","unstructured":"Glass M, Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17:5327\u20135333","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner JE","year":"2005","unstructured":"Lauckner JE, Hille B, Mackie K (2005) The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins. Proc Natl Acad Sci USA 102:19144\u201319149. 10.1073\/pnas.0509588102","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.mie.2017.06.031","article-title":"Approaches to Assess Biased Signaling at the CB1R Receptor","volume":"593","author":"Laprairie RB","year":"2017","unstructured":"Laprairie RB, Stahl EL, Bohn LM (2017) Approaches to Assess Biased Signaling at the CB1R Receptor. Methods Enzymol 593:259\u2013279. 10.1016\/bs.mie.2017.06.031","journal-title":"Methods Enzymol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41589-023-01292-8","article-title":"A community Biased Signaling Atlas","volume":"19","author":"Caroli J","year":"2023","unstructured":"Caroli J et al (2023) A community Biased Signaling Atlas. Nat Chem Biol 19:531\u2013535. 10.1038\/s41589-023-01292-8","journal-title":"Nat Chem Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081837","article-title":"Structural Insights into CB1 Receptor Biased Signaling","volume":"20","author":"Al-Zoubi R","year":"2019","unstructured":"Al-Zoubi R, Morales P, Reggio PH (2019) Structural Insights into CB1 Receptor Biased Signaling. Int J Mol Sci 20. 10.3390\/ijms20081837","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith JS","year":"2018","unstructured":"Smith JS, Lefkowitz RJ, Rajagopal S (2018) Biased signalling: from simple switches to allosteric microprocessors. Nat Rev Drug Discov 17:243\u2013260. 10.1038\/nrd.2017.229","journal-title":"Nat Rev Drug Discov"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin T","year":"2013","unstructured":"Kenakin T, Christopoulos A (2013) Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 12:205\u2013216. 10.1038\/nrd3954","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB(1)","volume":"547","author":"Hua T","year":"2017","unstructured":"Hua T et al (2017) Crystal structures of agonist-bound human cannabinoid receptor CB(1). Nature 547:468\u2013471. 10.1038\/nature23272","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.01.008","author":"Hua T","year":"2020","unstructured":"Hua T et al (2020) Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G(i) Complex Structures. Cell 180, 655\u2013665 e618, 10.1016\/j.cell.2020.01.008"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"16320","DOI":"10.1021\/jacs.1c06847","article-title":"A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1","volume":"143","author":"Wang X","year":"2021","unstructured":"Wang X et al (2021) A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1. J Am Chem Soc 143:16320\u201316325. 10.1021\/jacs.1c06847","journal-title":"J Am Chem Soc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41589-022-01038-y","article-title":"Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1","volume":"18","author":"Yang X","year":"2022","unstructured":"Yang X et al (2022) Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. Nat Chem Biol 18:831\u2013840. 10.1038\/s41589-022-01038-y","journal-title":"Nat Chem Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-019-0387-2","article-title":"Structure of an allosteric modulator bound to the CB1 cannabinoid receptor","volume":"15","author":"Shao Z","year":"2019","unstructured":"Shao Z et al (2019) Structure of an allosteric modulator bound to the CB1 cannabinoid receptor. Nat Chem Biol 15:1199\u20131205. 10.1038\/s41589-019-0387-2","journal-title":"Nat Chem Biol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41467-023-37112-9","article-title":"Structural basis of selective cannabinoid CB(2) receptor activation","volume":"14","author":"Li X","year":"2023","unstructured":"Li X et al (2023) Structural basis of selective cannabinoid CB(2) receptor activation. Nat Commun 14:1447. 10.1038\/s41467-023-37112-9","journal-title":"Nat Commun"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2004.01.023","article-title":"6-Azidohex-2-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist","volume":"487","author":"Thomas A","year":"2004","unstructured":"Thomas A et al (2004) 6-Azidohex-2-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist. Eur J Pharmacol 487:213\u2013221. 10.1016\/j.ejphar.2004.01.023","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1021\/jm00089a018","article-title":"A novel probe for the cannabinoid receptor","volume":"35","author":"Devane WA","year":"1992","unstructured":"Devane WA et al (1992) A novel probe for the cannabinoid receptor. J Med Chem 35:2065\u20132069. 10.1021\/jm00089a018","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/cbdv.200790149","article-title":"Medicinal chemistry endeavors around the phytocannabinoids","volume":"4","author":"Stern E","year":"2007","unstructured":"Stern E, Lambert DM (2007) Medicinal chemistry endeavors around the phytocannabinoids. Chem Biodivers 4:1707\u20131728. 10.1002\/cbdv.200790149","journal-title":"Chem Biodivers"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1021\/jm970126f","article-title":"Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase","volume":"40","author":"Rhee MH","year":"1997","unstructured":"Rhee MH et al (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40:3228\u20133233. 10.1021\/jm970126f","journal-title":"J Med Chem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630","volume":"126","author":"Ross RA","year":"1999","unstructured":"Ross RA et al (1999) Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126:665\u2013672. 10.1038\/sj.bjp.0702351","journal-title":"Br J Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity","volume":"8","author":"Soethoudt M","year":"2017","unstructured":"Soethoudt M et al (2017) Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity. Nat Commun 8:13958. 10.1038\/ncomms13958","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42238-020-0016-7","article-title":"Delta9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes","volume":"2","author":"Abioye A","year":"2020","unstructured":"Abioye A et al (2020) Delta9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. J Cannabis Res 2:6. 10.1186\/s42238-020-0016-7","journal-title":"J Cannabis Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0009-3084(00)00186-9","article-title":"Molecular probes for the cannabinoid receptors","volume":"108","author":"Khanolkar AD","year":"2000","unstructured":"Khanolkar AD, Palmer SL, Makriyannis A (2000) Molecular probes for the cannabinoid receptors. Chem Phys Lipids 108:37\u201352. 10.1016\/s0009-3084(00)00186-9","journal-title":"Chem Phys Lipids"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23071526","article-title":"Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases","volume":"23","author":"Prandi C","year":"2018","unstructured":"Prandi C, Blangetti M, Namdar D, Koltai H (2018) Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases. Molecules 23. 10.3390\/molecules23071526","journal-title":"Molecules"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4137\/pmc.S32171","article-title":"The Structure-Function Relationships of Classical Cannabinoids: CB1\/CB2 Modulation","volume":"8","author":"Bow EW","year":"2016","unstructured":"Bow EW, Rimoldi JM (2016) The Structure-Function Relationships of Classical Cannabinoids: CB1\/CB2 Modulation. Perspect Medicin Chem 8:17\u201339. 10.4137\/pmc.S32171","journal-title":"Perspect Medicin Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0022-3565(24)35007-4","article-title":"Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists","volume":"290","author":"Martin BR","year":"1999","unstructured":"Martin BR et al (1999) Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists. J Pharmacol Exp Ther 290:1065\u20131079","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ncomms1559","article-title":"TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid \u2206(9)-tetrahydrocannabiorcol","volume":"2","author":"Andersson DA","year":"2011","unstructured":"Andersson DA et al (2011) TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid \u2206(9)-tetrahydrocannabiorcol. Nat Commun 2:551. 10.1038\/ncomms1559","journal-title":"Nat Commun"},{"key":"ref34","first-page":"75","article-title":"Structure-activity relationships in cannabinoids","volume":"38","author":"Razdan RK","year":"1986","unstructured":"Razdan RK (1986) Structure-activity relationships in cannabinoids. Pharmacol Rev 38:75\u2013149","journal-title":"Pharmacol Rev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas A","year":"2005","unstructured":"Thomas A et al (2005) Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol 146:917\u2013926. 10.1038\/sj.bjp.0706414","journal-title":"Br J Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/aps.2016.69","article-title":"The structural basis of the dominant negative phenotype of the G\u03b1i1\u03b21\u03b32 G203A\/A326S heterotrimer","volume":"37","author":"Liu P","year":"2016","unstructured":"Liu P et al (2016) The structural basis of the dominant negative phenotype of the G\u03b1i1\u03b21\u03b32 G203A\/A326S heterotrimer. Acta Pharmacol Sin 37:1259\u20131272. 10.1038\/aps.2016.69","journal-title":"Acta Pharmacol Sin"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-018-0215-y","article-title":"Cryo-EM structure of human rhodopsin bound to an inhibitory G protein","volume":"558","author":"Kang Y","year":"2018","unstructured":"Kang Y et al (2018) Cryo-EM structure of human rhodopsin bound to an inhibitory G protein. Nature 558:553\u2013558. 10.1038\/s41586-018-0215-y","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41467-023-37864-4","article-title":"Structural basis for activation of CB1 by an endocannabinoid analog","volume":"14","author":"Krishna Kumar K","year":"2023","unstructured":"Krishna Kumar K et al (2023) Structural basis for activation of CB1 by an endocannabinoid analog. Nat Commun 14:2672. 10.1038\/s41467-023-37864-4","journal-title":"Nat Commun"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.11.040","author":"Krishna Kumar K","year":"2019","unstructured":"Krishna Kumar K et al (2019) Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex. Cell 176, 448\u2013458 e412, 10.1016\/j.cell.2018.11.040"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1111\/bph.15811","article-title":"Community guidelines for GPCR ligand bias: IUPHAR review 32","volume":"179","author":"Kolb P","year":"2022","unstructured":"Kolb P et al (2022) Community guidelines for GPCR ligand bias: IUPHAR review 32. Br J Pharmacol 179:3651\u20133674. 10.1111\/bph.15811","journal-title":"Br J Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1124\/mol.105.014407","article-title":"-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor","volume":"68","author":"Picone RP","year":"2005","unstructured":"Picone RP et al (2005) (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor. Mol Pharmacol 68:1623\u20131635. 10.1124\/mol.105.014407","journal-title":"Mol Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.chembiol.2008.10.011","article-title":"Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation","volume":"15","author":"Pei Y","year":"2008","unstructured":"Pei Y et al (2008) Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation. Chem Biol 15:1207\u20131219. 10.1016\/j.chembiol.2008.10.011","journal-title":"Chem Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1021\/pr2005583","article-title":"Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation","volume":"10","author":"Szymanski DW","year":"2011","unstructured":"Szymanski DW et al (2011) Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation. J Proteome Res 10:4789\u20134798. 10.1021\/pr2005583","journal-title":"J Proteome Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1021\/acs.jmedchem.0c02053","article-title":"Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists","volume":"64","author":"Jiang S","year":"2021","unstructured":"Jiang S et al (2021) Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists. J Med Chem 64:3870\u20133884. 10.1021\/acs.jmedchem.0c02053","journal-title":"J Med Chem"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2014.01.041","article-title":"The cannabinoid agonist HU-210: Pseudo-irreversible discriminative stimulus effects in rhesus monkeys","volume":"727","author":"Hruba L","year":"2014","unstructured":"Hruba L, McMahon LR (2014) The cannabinoid agonist HU-210: Pseudo-irreversible discriminative stimulus effects in rhesus monkeys. Eur J Pharmacol 727:35\u201342. https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.041","journal-title":"Eur J Pharmacol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41592-020-0884-y","article-title":"GPCRmd uncovers the dynamics of the 3D-GPCRome","volume":"17","author":"Rodriguez-Espigares I","year":"2020","unstructured":"Rodriguez-Espigares I et al (2020) GPCRmd uncovers the dynamics of the 3D-GPCRome. Nat Methods 17:777\u2013787. 10.1038\/s41592-020-0884-y","journal-title":"Nat Methods"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41589-022-01247-5","article-title":"Structural basis of efficacy-driven ligand selectivity at GPCRs","volume":"19","author":"Powers AS","year":"2023","unstructured":"Powers AS et al (2023) Structural basis of efficacy-driven ligand selectivity at GPCRs. Nat Chem Biol 19:805\u2013814. 10.1038\/s41589-022-01247-5","journal-title":"Nat Chem Biol"},{"key":"ref48","author":"AlphaFold","year":"2023","unstructured":"AlphaFold (2023) Google DeepMind"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.09.561603","article-title":"Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom. bioRxiv, 2023.2010.2009.561603","author":"Krishna R","year":"2023","unstructured":"Krishna R et al (2023) Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom. bioRxiv, 2023.2010.2009.561603. 10.1101\/2023.10.09.561603"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41594-021-00674-7","article-title":"GPCR activation mechanisms across classes and macro\/microscales","volume":"28","author":"Hauser AS","year":"2021","unstructured":"Hauser AS et al (2021) GPCR activation mechanisms across classes and macro\/microscales. Nat Struct Mol Biol 28:879\u2013888. 10.1038\/s41594-021-00674-7","journal-title":"Nat Struct Mol Biol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor","volume":"88","author":"Khajehali E","year":"2015","unstructured":"Khajehali E et al (2015) Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor. Mol Pharmacol 88:368\u2013379. 10.1124\/mol.115.099192","journal-title":"Mol Pharmacol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"24845","DOI":"10.1074\/jbc.M114.557025","article-title":"Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons*","volume":"289","author":"Laprairie RB","year":"2014","unstructured":"Laprairie RB, Bagher AM, Kelly MEM, Dupr\u00e9 DJ, Denovan-Wright EM (2014) Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons*. J Biol Chem 289:24845\u201324862. https:\/\/doi.org\/10.1074\/jbc.M114.557025","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin BR","year":"1991","unstructured":"Martin BR et al (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471\u2013478. 10.1016\/0091-3057(91)90349-7","journal-title":"Pharmacol Biochem Behav"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/aps.2016.69","article-title":"The structural basis of the dominant negative phenotype of the Galphai1beta1gamma2 G203A\/A326S heterotrimer","volume":"37","author":"Liu P","year":"2016","unstructured":"Liu P et al (2016) The structural basis of the dominant negative phenotype of the Galphai1beta1gamma2 G203A\/A326S heterotrimer. Acta Pharmacol Sin 37:1259\u20131272. 10.1038\/aps.2016.69","journal-title":"Acta Pharmacol Sin"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1038\/s41467-018-06002-w","article-title":"Development of an antibody fragment that stabilizes GPCR\/G-protein complexes","volume":"9","author":"Maeda S","year":"2018","unstructured":"Maeda S et al (2018) Development of an antibody fragment that stabilizes GPCR\/G-protein complexes. Nat Commun 9:3712. 10.1038\/s41467-018-06002-w","journal-title":"Nat Commun"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani A","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA (2017) cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14:290\u2013296. 10.1038\/nmeth.4169","journal-title":"Nat Methods"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov J","year":"2018","unstructured":"Zivanov J et al (2018) New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7. 10.7554\/eLife.42166","journal-title":"Elife"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s42003-019-0437-z","article-title":"SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM","volume":"2","author":"Wagner T","year":"2019","unstructured":"Wagner T et al (2019) SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun Biol 2:218. 10.1038\/s42003-019-0437-z","journal-title":"Commun Biol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"107545","DOI":"10.1016\/j.jsb.2020.107545","article-title":"S. Mitigating local over-fitting during single particle reconstruction with SIDESPLITTER","volume":"211","author":"Ramlaul K","year":"2020","unstructured":"Ramlaul K, Palmer CM, Nakane T, Aylett CH (2020) S. Mitigating local over-fitting during single particle reconstruction with SIDESPLITTER. J Struct Biol 211:107545. 10.1016\/j.jsb.2020.107545","journal-title":"J Struct Biol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1038\/s41467-018-06002-w","article-title":"Development of an antibody fragment that stabilizes GPCR\/G-protein complexes","volume":"9","author":"Maeda S","year":"2018","unstructured":"Maeda S et al (2018) Development of an antibody fragment that stabilizes GPCR\/G-protein complexes. Nat Commun 9:3712. 10.1038\/s41467-018-06002-w","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley P","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486\u2013501. 10.1107\/S0907444910007493","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner D","year":"2019","unstructured":"Liebschner D et al (2019) Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75:861\u2013877. 10.1107\/S2059798319011471","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-0716-0892-0_14","article-title":"Protein Structure Modeling with MODELLER","volume":"2199","author":"Webb B","year":"2021","unstructured":"Webb B, Sali A (2021) Protein Structure Modeling with MODELLER. Methods Mol Biol 2199:239\u2013255. 10.1007\/978-1-0716-0892-0_14","journal-title":"Methods Mol Biol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry G","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. 10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","article-title":"OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules","volume":"15","author":"Roos K","year":"2019","unstructured":"Roos K et al (2019) OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules. J Chem Theory Comput 15:1863\u20131874. 10.1021\/acs.jctc.8b01026","journal-title":"J Chem Theory Comput"},{"key":"ref66","unstructured":"Small Molecule Drug Discovery Suite (2023) (Schr\u00f6dinger LLC"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pKa and Protonation State Prediction through Machine Learning","volume":"19","author":"Johnston RC","year":"2023","unstructured":"Johnston RC et al (2023) Epik: pKa and Protonation State Prediction through Machine Learning. J Chem Theory Comput 19:2380\u20132388. 10.1021\/acs.jctc.3c00044","journal-title":"J Chem Theory Comput"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM web server: resources for positioning of proteins in membranes","volume":"40","author":"Lomize MA","year":"2012","unstructured":"Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL (2012) OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res 40:D370\u2013376. 10.1093\/nar\/gkr703","journal-title":"Nucleic Acids Res"},{"key":"ref69","unstructured":"Maestro-Desmond Interoperability Tools (D. E (2023) Shaw Research & Schr\u00f6dinger, New York, NY"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden T","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems. J Chem Phys 98:10089\u201310092. 10.1063\/1.464397","journal-title":"J Chem Phys"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1101\/840694","article-title":"Uncovering patterns of atomic interactions in static and dynamic structures of proteins","volume":"840694","author":"Venkatakrishnan AJ","year":"2019","unstructured":"Venkatakrishnan AJ et al (2019) Uncovering patterns of atomic interactions in static and dynamic structures of proteins. bioRxiv 840694. 10.1101\/840694","journal-title":"bioRxiv"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.RA118.001975","article-title":"Mini G protein probes for active G protein\u2013coupled receptors (GPCRs) in live cells","volume":"293","author":"Wan Q","year":"2018","unstructured":"Wan Q et al (2018) Mini G protein probes for active G protein\u2013coupled receptors (GPCRs) in live cells. J Biol Chem 293:7466\u20137473. https:\/\/doi.org\/10.1074\/jbc.RA118.001975","journal-title":"J Biol Chem"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1208\/aapsj060430","article-title":"The role of halogen substitution in classical cannabinoids: a CB1 pharmacophore model","volume":"6","author":"Nikas SP","year":"2004","unstructured":"Nikas SP et al (2004) The role of halogen substitution in classical cannabinoids: a CB1 pharmacophore model. AAPS J 6:e30. 10.1208\/aapsj060430","journal-title":"AAPS J"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41594-021-00675-6","article-title":"An online GPCR structure analysis platform","volume":"28","author":"Kooistra AJ","year":"2021","unstructured":"Kooistra AJ, Munk C, Hauser AS, Gloriam DE (2021) An online GPCR structure analysis platform. Nat Struct Mol Biol 28:875\u2013878. 10.1038\/s41594-021-00675-6","journal-title":"Nat Struct Mol Biol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","article-title":"Generic GPCR residue numbers - aligning topology maps while minding the gaps","volume":"36","author":"Isberg V","year":"2015","unstructured":"Isberg V et al (2015) Generic GPCR residue numbers - aligning topology maps while minding the gaps. Trends Pharmacol Sci 36:22\u201331. 10.1016\/j.tips.2014.11.001","journal-title":"Trends Pharmacol Sci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4277209\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4277209\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:07:29Z","timestamp":1736410049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4277209\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":75,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4277209\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-024-55808-4","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,5,21]]},"subtype":"preprint"}}